Summit Therapeutics Inc. SEC filings SMMT

Summit Therapeutics Inc. has 564 filings in SEC EDGAR's recent list, going back to Mar 4, 2014. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.

Summit Therapeutics Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 4, 2026 Nov 4, 2026
424B7 Filing Nov 4, 2026 —
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations, Bylaw or fiscal year change, Shareholder vote results
Nov 4, 2026 Nov 4, 2026
DEF 14A Proxy statement Oct 19, 2026 Nov 4, 2026
PRE 14A Preliminary proxy statement Oct 6, 2026 Oct 6, 2026
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Sep 29, 2026 Sep 28, 2026
8-K Current report
Other events
Sep 15, 2026 Sep 15, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 13, 2026
8-K Current report
Other events
Sep 3, 2026 Sep 2, 2026
8-K Current report
Other events
Aug 26, 2026 Aug 25, 2026
8-K Current report
Other events
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement
Jul 23, 2026 Jul 23, 2026
424B5 Prospectus supplement Jul 23, 2026 —
10-Q Quarterly report Jul 23, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 23, 2026 Jul 23, 2026
8-K Current report
Other events
Jul 22, 2026 Jul 22, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 10, 2026
8-K Current report
Regulation FD disclosure
Jun 11, 2026 Jun 10, 2026
424B5 Prospectus supplement Jun 10, 2026 —
S-3ASR Automatic shelf registration Jun 9, 2026 —
8-K Current report
Other events
Jun 3, 2026 Jun 2, 2026
8-K Current report
Other events
Jun 1, 2026 May 30, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
UPLOAD Letter from the SEC Apr 27, 2026 —
DEFA14A Additional proxy material Apr 17, 2026 —
ARS Annual report to shareholders Apr 17, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 17, 2026 Apr 17, 2026
CORRESP Letter to the SEC Apr 16, 2026 —
PRE 14A Preliminary proxy statement Apr 6, 2026 Apr 6, 2026
UPLOAD Letter from the SEC Apr 2, 2026 —
S-8 Employee stock plan registration Feb 23, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 23, 2026 Feb 23, 2026
8-K Current report
Other events
Jan 29, 2026 Jan 29, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Nov 7, 2025 Nov 7, 2025
S-3ASR Automatic shelf registration Oct 29, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 22, 2025 Oct 21, 2025
10-Q Quarterly report Oct 20, 2025 Sep 30, 2025
8-K Current report
Results of operations, Other events
Oct 20, 2025 Oct 17, 2025
8-K Current report
Other events
Sep 8, 2025 Sep 7, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Material agreement
Aug 11, 2025 Aug 11, 2025
424B5 Prospectus supplement Aug 11, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Material agreement
Jun 20, 2025 Jun 16, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 12, 2025
8-K Current report
Other events
May 30, 2025 May 30, 2025
S-8 Employee stock plan registration May 19, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Jun 12, 2025
8-K Current report
Other events
Apr 25, 2025 Apr 25, 2025
8-K Current report
Other events
Apr 23, 2025 Apr 23, 2025
10-K Annual report Feb 24, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 24, 2025 Feb 24, 2025
8-K Current report
Officer or director change, Other events
Jan 24, 2025 Jan 22, 2025
UPLOAD Letter from the SEC Jan 21, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
CORRESP Letter to the SEC Jan 6, 2025 —
UPLOAD Letter from the SEC Dec 19, 2024 —
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 30, 2024 Oct 30, 2024
D Filing Sep 26, 2024 —
S-3ASR Automatic shelf registration Sep 19, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 12, 2024 Sep 11, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2024 Sep 8, 2024
S-3ASR Automatic shelf registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
8-K Current report
Material agreement, Officer or director change
Jun 27, 2024 Jun 27, 2024
D Filing Jun 18, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2024 Jun 12, 2024
DEFA14A Additional proxy material Jun 13, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 3, 2024 Jun 3, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 3, 2024 May 31, 2024
8-K Current report
Other events
May 30, 2024 May 30, 2024
8-K Current report
Other events
May 24, 2024 May 24, 2024
8-K Current report
Material agreement
May 13, 2024 May 13, 2024
424B5 Prospectus supplement May 13, 2024 —
S-8 Employee stock plan registration May 1, 2024 —
8-K Current report
Results of operations
May 1, 2024 May 1, 2024
10-Q Quarterly report May 1, 2024 Mar 31, 2024
DEF 14A Proxy statement Apr 25, 2024 Jun 14, 2024
8-K Current report
Officer or director change
Apr 11, 2024 Apr 11, 2024
8-K Current report
Officer or director change
Apr 3, 2024 Apr 2, 2024
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
8-K Current report
Regulation FD disclosure
Mar 12, 2024 Mar 12, 2024
8-K Current report
Other events
Mar 5, 2024 Mar 5, 2024
EFFECT Filing Feb 27, 2024 —
CORRESP Letter to the SEC Feb 23, 2024 —
UPLOAD Letter from the SEC Feb 22, 2024 —
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
S-3 Shelf registration Feb 20, 2024 —
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Feb 15, 2024 Feb 14, 2024
8-K Current report
Other events
Feb 8, 2024 Feb 7, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Other events
Jan 3, 2024 Jan 3, 2024
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Oct 31, 2023 Oct 31, 2023
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Shareholder vote results, Other events
Oct 16, 2023 Oct 12, 2023
DEF 14A Proxy statement Sep 19, 2023 Oct 12, 2023
PRE 14A Preliminary proxy statement Sep 8, 2023 Sep 8, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Regulation FD disclosure
Jun 5, 2023 Jun 4, 2023
8-K Current report
Other events
Jun 1, 2023 Jun 1, 2023
8-K Current report
Shareholder vote results
May 25, 2023 May 23, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
May 9, 2023 May 9, 2023
8-K Current report
Other events
May 3, 2023 May 3, 2023
EFFECT Filing Apr 27, 2023 —
CORRESP Letter to the SEC Apr 25, 2023 —
DEF 14A Proxy statement Apr 21, 2023 May 23, 2023
UPLOAD Letter from the SEC Mar 22, 2023 —
8-K Current report
Other events
Mar 17, 2023 Mar 17, 2023
S-3 Shelf registration Mar 17, 2023 —
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
8-K Current report
Other events
Mar 3, 2023 Mar 1, 2023
8-K Current report
Other events
Feb 23, 2023 Feb 23, 2023
424B4 Prospectus Feb 7, 2023 —
EFFECT Filing Feb 3, 2023 —
CORRESP Letter to the SEC Jan 31, 2023 —
8-K Current report
Other events
Jan 30, 2023 Jan 30, 2023
8-K Current report
Other events
Jan 27, 2023 Jan 27, 2023
S-3/A Amendment to form s-3 Jan 23, 2023 —
CORRESP Letter to the SEC Jan 20, 2023 —
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
Jan 20, 2023 Jan 16, 2023
UPLOAD Letter from the SEC Jan 12, 2023 —
8-K Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
Jan 9, 2023 Jan 6, 2023
8-K Current report
Officer or director change
Dec 27, 2022 Dec 22, 2022
8-K Current report
Other events
Dec 21, 2022 Dec 21, 2022
S-3 Shelf registration Dec 21, 2022 —
10-K/A Amended annual report Dec 21, 2022 Dec 31, 2021
DEF 14A Proxy statement Dec 13, 2022 Jan 6, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Other events
Dec 6, 2022 Dec 5, 2022
PRE 14A Preliminary proxy statement Nov 29, 2022 Nov 29, 2022
8-K Current report
Officer or director change
Nov 17, 2022 Nov 15, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Regulation FD disclosure
Oct 20, 2022 Oct 20, 2022
8-K Current report
Other events
Oct 4, 2022 Sep 28, 2022
8-K Current report
Officer or director change
Oct 3, 2022 Sep 28, 2022
8-K Current report
Other events
Aug 16, 2022 Aug 15, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Other events
Aug 9, 2022 Aug 9, 2022
8-K Current report
Results of operations
Aug 2, 2022 Aug 2, 2022
8-K Current report
Shareholder vote results, Other events
Jul 29, 2022 Jul 27, 2022
8-K Current report
Officer or director change
Jul 26, 2022 Jul 25, 2022
8-K Current report
Other events
Jul 18, 2022 Jul 18, 2022
424B4 Prospectus Jul 18, 2022 —
8-K Current report
Other events
Jul 14, 2022 Jul 14, 2022
DEF 14A Proxy statement Jul 6, 2022 Jul 6, 2022
PRE 14A Preliminary proxy statement Jun 24, 2022 Jul 27, 2022
8-K Current report
Other events
Jun 22, 2022 Jun 22, 2022
8-K Current report
Shareholder vote results
Jun 22, 2022 Jun 16, 2022
DEFA14A Additional proxy material Jun 3, 2022 —
8-K Current report
Officer or director change
Jun 1, 2022 Jun 1, 2022
10-Q Quarterly report May 11, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 11, 2022 May 11, 2022
DEF 14A Proxy statement Apr 29, 2022 Jun 15, 2022
CT ORDER Filing Apr 14, 2022 —
CT ORDER Filing Apr 14, 2022 —
S-8 Employee stock plan registration Apr 6, 2022 —
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
8-K Current report
Material agreement, New debt
Mar 11, 2022 Mar 10, 2022
8-K Current report
Other events
Feb 9, 2022 Feb 9, 2022
8-K Current report
Other events
Jan 25, 2022 Jan 25, 2022
8-K Current report
Officer or director change
Jan 12, 2022 Jan 7, 2022
8-K Current report
Regulation FD disclosure
Dec 20, 2021 Dec 20, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Officer or director change, Other events
Nov 3, 2021 Nov 3, 2021
8-K Current report
Officer or director change, Other events
Oct 8, 2021 Oct 7, 2021
8-K Current report
Other events
Sep 21, 2021 Sep 21, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 11, 2021 Aug 11, 2021
8-K Current report
Other events
Aug 11, 2021 Aug 11, 2021
8-K Current report
Officer or director change
Jul 9, 2021 Jul 2, 2021
8-K Current report
Shareholder vote results
Jun 22, 2021 Jun 16, 2021
CT ORDER Filing Jun 17, 2021 —
DEFA14A Additional proxy material Jun 2, 2021 —
8-K Current report
Officer or director change
May 28, 2021 May 28, 2021
8-K Current report
Auditor change
May 26, 2021 May 24, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Other events
May 13, 2021 May 12, 2021
8-K Current report
Other events
May 7, 2021 May 5, 2021
8-K Current report
Officer or director change
May 4, 2021 Apr 28, 2021
DEF 14A Proxy statement Apr 29, 2021 Jun 16, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SMMT (Nasdaq)
Fiscal year ends
December 31
Headquarters
Miami, FL
SEC filer status
Large accelerated filer
SEC CIK
1599298
Former names
Summit Therapeutics plc (until Sep 17, 2020); Summit Corp plc (until Jan 30, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.